Related Experiment Video
Updated: Feb 22, 2026

10:01
Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
Published on: October 17, 2018
8.5K
[Progress in Zika virus and its vaccines]
1Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology
|September 30, 2017
Summary
Zika virus, a mosquito-borne flavivirus, is now a global concern due to outbreaks and associated microcephaly. This review covers Zika virus biology, epidemiology, and clinical features, alongside vaccine development progress.
Area of Science:
- Virology
- Epidemiology
- Vaccinology
Background:
- Zika virus is a mosquito-borne flavivirus, previously of limited concern due to restricted distribution and mild symptoms.
- Recent outbreaks, notably in Brazil since 2015, have elevated Zika virus to a global health concern due to its association with microcephaly.
Purpose of the Study:
- To review the biology, epidemiology, and clinical features of Zika virus.
- To summarize the current research and development of various Zika virus vaccines.
- To provide a reference for Zika vaccine researchers by including information on other flavivirus vaccines.
Main Methods:
- Literature review of Zika virus biology, epidemiology, and clinical manifestations.
- Survey of ongoing Zika vaccine research and development efforts.
- Brief overview of approved and investigational flavivirus vaccines.
Main Results:
- Zika virus, while historically less concerning, poses significant risks, particularly regarding microcephaly.
- Numerous institutions worldwide are actively developing diverse types of Zika virus vaccines.
- Existing flavivirus vaccine data offers valuable insights for Zika vaccine development.
Conclusions:
- Understanding Zika virus's characteristics is crucial for effective disease control.
- Accelerated development of Zika virus vaccines is a global priority.
- Comparative analysis of flavivirus vaccines can inform and expedite Zika vaccine research.

